![We are proud to collaborate with MENARINI Group and Natera Oncology on EORTC 2129-BCG TREAT ctDNA – EORTC](https://oncodaily.com/pub/uploads/2023/11/download-31-1-1280x720.jpg)
Photo taken from youtube.com
Nov 15, 2023, 17:25
We are proud to collaborate with MENARINI Group and Natera Oncology on EORTC 2129-BCG TREAT ctDNA – EORTC
EORTC – European Organization for Research and Treatment of Cancer shared
“We are proud to collaborate with MENARINI Group and Natera Oncology on EORTC 2129-BCG TREAT ctDNA, an international, multi-center, randomized, phase III clinical trial on high-risk, ctDNA positive, ER+/HER2- early-stage breast cancer. Read the article here.”
Quoting :